Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
For years this comparison was guesswork across separate trials with different populations. SURMOUNT-5 finally ran them against each other — 751 adults, 72 weeks, maximum tolerated doses. Tirzepatide won on weight, and that is not the whole answer.
Do not read −22.8 kg as a personal forecast. That is a trial average across 751 people, and individual response varies enormously in both directions. Trial populations are also screened, supported and monitored in ways ordinary care is not. Real-world results are typically more modest than trial results for both drugs.
Note what the trial compared: maximum tolerated doses over 72 weeks. That is the fairest possible test and also the most demanding one. If you cannot tolerate titrating to a high dose — and a meaningful number of people cannot, because of gastrointestinal side effects — the gap between the two drugs at the dose you can actually stay on may be considerably smaller than the headline figures suggest.
Both drugs carry the same boxed warning regarding thyroid C-cell tumours observed in rodent studies. Both are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Both require caution in people with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease or diabetic retinopathy. This is a conversation with a clinician who knows your history, not a choice to make from a comparison table.
There is a practical asymmetry worth knowing: because tirzepatide produces greater average weight loss, it also tends to produce faster weight loss, and rapid loss is associated with a higher risk of gallstones and greater loss of lean mass. That is an argument for adequate protein intake and resistance training on either drug, and a reason not to assume that faster is automatically better for you.
That last point is the one most likely to be glossed over in marketing. If a telehealth provider cites SURMOUNT-5 or the SURMOUNT and STEP trial results while selling you a compounded preparation, understand that the evidence being quoted was generated using a different product than the one being sold to you.
Switching between them is possible and reasonably common, but doses are not interchangeable — 2.4 mg of semaglutide does not map onto any particular dose of tirzepatide, and switching usually means re-titrating from a low dose. That is a prescriber's decision, not a self-managed one. If your current drug is not working or not tolerable, raise switching at a visit rather than sourcing an alternative independently.
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.
Med Consumer Watch GLP-1 plans
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Medication, clinician review and shipping are included. See your total before you buy.
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Compounded
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Compounded
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.